Results 121 to 130 of about 1,935,200 (187)

A Comprehensive Meta-Analysis of Bioadaptor Versus Drug-Eluting Stents in Randomised Trials With Exploratory Single-Arm Landmark Analyses. [PDF]

Eur J Clin Invest
Wölbert S, Kühne S, Patrignani A, Chiarito M, von Scheidt M, Torzewski J, Raake P, Bongiovanni D.   +7 more
europepmc   +1 more source

Ultrathin-strut drug-eluting stents are associated with lower revascularization rates than drug-coated balloons in non-focal in-stent restenosis. [PDF]

Front Cardiovasc Med
Keskin B, Hakgor A, Dursun A, Akhundova A, Savur U, Yigitbay E, Onder O, Cakal B, Bayram Z, Demir B, Gunes HM, Karaca IO, Guler E, Boztosun B.   +13 more
europepmc   +1 more source

State-of-the-Art Review on Finite Element Analysis Applied to Ultrathin-Strut Drug-Eluting Stents: Examining the Present and Looking Ahead to the Future. [PDF]

Bioengineering (Basel)
Nappi F, Digne F.
europepmc   +1 more source

Improvements of Blood Compatibility, Drug-in-Polymer Coating Stability and Prevention of Crack Formation: Application to Drug-Eluting Stents. [PDF]

Pharmaceutics
Bedair TM, Han DK.
europepmc   +1 more source

Dual antiplatelet therapy duration after percutaneous coronary intervention with contemporary drug-eluting stents: A systematic review and network meta-analysis of randomized trials. [PDF]

PLoS One
Hlupeni A, Jalilzadehbinazar M, Liceralde RJ, Khan HAM, Donepudi R, Arora S.   +5 more
europepmc   +1 more source

Sex-related differences in long-term outcomes of drug-coated balloons versus thin-strut drug-eluting stents in the treatment of in-stent restenosis (DCB-DRAGON Registry). [PDF]

Postepy Kardiol Interwencyjnej
Januszek R, Tarnowski M, Pawlus P, Iwańczyk S, Kuźma Ł, Tomasiewicz B, Kubler P, Wybraniec M, Wita K, Dobrzycki S, Bartuś S, Lesiak M, Gil RJ, Chamera M, Pawłowski T, Kowalewski M, Grzegorek D, Mezque F, Stanek A, Gurgoglione FL, Cortese B, D'Ascenzo F, Hudziak D, Wolny R, Kowalówka A, Smolka G, Sobieszek G, Wojakowski W, Wańha W.   +28 more
europepmc   +1 more source

Non-vascular drug eluting stents as localized controlled drug delivery platform: Preclinical and clinical experience

, 2013
Stents occupy an important place in the medical field for their widespread application. They have been used in vascular as well as in non-vascular organs for various reasons.
Mohsin Shaikh (805265), Ganessan Kichenadasse (9120341), Sanjay Garg (805267), Namita Roy Choudhury (18029617), Ross Butler (87207)   +4 more
core  

Clinical efficacy of drug-eluting stents in the treatment of vertebral artery stenosis and analysis of factors contributing to stent restenosis. [PDF]

Front Neurol
Wei X, Ma Z, Wu H, Jiang H, Lan W, Xu L, Du M, Cao H, Wang X, Qiu F.   +9 more
europepmc   +1 more source

Outcomes of durable versus biodegradable polymer drug-eluting stents in patients with coronary artery disease. [PDF]

Int J Cardiol Heart Vasc
Skos C, Rogozarski J, Dizdarevic AM, M Steiner-Gager G, Postula M, Eyileten C, Toma A, Speidl WS, Skoro-Sajer N, Gerges C, Lang IM, Siller-Matula JM.   +11 more
europepmc   +1 more source

Drug-Coated Balloons Versus Drug-Eluting Stents for Patients With Long De Novo Coronary Artery Lesions: Insights From the REC-CAGEFREE I Trial. [PDF]

Catheter Cardiovasc Interv
Lv Y, Yang F, Bai X, Wang H, Wu Y, Fang Z, Zhou J, Gao H, Hu T, Sun D, Wang Q, Yin Z, Wen S, Jin Y, Hong L, Liu J, Fu G, Zhang R, He X, Zhu B, Jiang Z, Xia J, Capodanno D, Garg S, Onuma Y, Wang D, Serruys PW, Tao L, Gao C.   +28 more
europepmc   +1 more source